In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.
about
Melanized fungi in human diseaseInfections caused by Scedosporium spp.Fusarium infections in immunocompromised patientsPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsMadurella mycetomatis is highly susceptible to ravuconazoleIn vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus speciesCurrent options in antifungal pharmacotherapy.New and investigational triazole agents for the treatment of invasive fungal infections.New generation azole antifungals in clinical investigation.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.Molecular identification and susceptibility of clinically relevant Scedosporium spp. in China.Newer antifungal agents.In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
P2860
Q24633163-ADF82D8F-093B-4E73-A567-B29692F91A1CQ24657691-F0C16AA4-C5CC-4DA0-8C6B-AD29EEB84F2CQ24685627-031D730A-7EAB-4923-9071-31BAD1AA1E70Q27025299-E4A29983-8C9F-407C-9667-F7E021329E93Q28539848-00290AFA-3AF5-465E-B338-0C71AB655EE6Q35960992-069CF147-F6A9-4A9F-BC22-BE9DEC2B419DQ37151326-4BFD4184-E19D-48D5-BC2B-95AAF7B03528Q37364295-07119FBB-F530-4A04-B278-05ACEC20900FQ37579222-14554D08-0E39-4EDF-8065-D232F920B94DQ37918556-0815DCC6-88FA-4832-8568-4F2990E72F3DQ41815954-59DB019D-ABB2-4BBA-8F14-6E9FC0754D4BQ41973262-74224C0A-6A34-4DF2-ADE6-1E0A9ED93F29Q42077007-5113EF29-5AE4-49B8-89E9-7DB91727BA4DQ44855715-5A884F97-A031-4074-AC30-3A450DA97596Q46863305-1D7EB74E-BA9D-40C0-9D97-AE97C65DD7E9Q58697730-27C69DE9-72C6-4BE5-9CDD-49D85CC5B7DB
P2860
In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In vitro activity of ravuconaz ...... ermatophyte filamentous fungi.
@en
type
label
In vitro activity of ravuconaz ...... ermatophyte filamentous fungi.
@en
prefLabel
In vitro activity of ravuconaz ...... ermatophyte filamentous fungi.
@en
P2093
P2860
P1476
In vitro activity of ravuconaz ...... dermatophyte filamentous fungi
@en
P2093
Alicia Gomez-Lopez
Araceli Monzon
Guillermo Garcia-Effron
Juan Luis Rodriguez-Tudela
Manuel Cuenca-Estrella
P2860
P304
P356
10.1128/AAC.49.12.5136-5138.2005
P407
P50
P577
2005-12-01T00:00:00Z